Annual report pursuant to Section 13 and 15(d)

Net Loss Per Common Share

v3.20.4
Net Loss Per Common Share
 12 Months Ended
Sep. 30, 2020
Net Loss Per Common Share  
Net Loss Per Common Share

12. Net Loss Per Common Share

The following potentially dilutive securities outstanding for the year ended September 30, 2020 and 2019 have been excluded from the computation of diluted weighted average shares outstanding, as they would be anti-dilutive:

 

 

 

 

 

 

 

    

As of September 30, 

 

 

2020

    

2019

Common stock purchase options

 

6,190,790

 

6,375,966

Unvested restricted stock

 

 —

 

6,875

Common stock purchase warrants

 

820,939

 

728,439

 

 

7,011,729

 

7,111,280